http://my.packexpo.com/NHL-7/Pharma-Medical-Device/Headlines.aspx2008 packexpoen-ushttp://my.packexpo.com/Skins/packexpo/365/logo.pnghttp://my.packexpo.com/Default.aspxPackaging News - Pharma/Medical DeviceTue, 02 Dec 2008 17:38:54 GMT60http://my.packexpo.com/NST-7-50148681/Johnson-Johnson-to-Buy-Implant-Maker-Mentor-for-1-07B.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 02 Dec 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50148681/Johnson-Johnson-to-Buy-Implant-Maker-Mentor-for-1-07B.aspxJ&J is looking to boost its presence in cosmetic and reconstructive medicine.http://my.packexpo.com/NST-7-50148787/More-Than-100-HIV-AIDS-Medications-and-Vaccines-in-Development.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 02 Dec 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50148787/More-Than-100-HIV-AIDS-Medications-and-Vaccines-in-Development.aspxMarking World AIDS Day, PhRMA reported yesterday that its members are committing significant resources to battle HIV/AIDS.http://my.packexpo.com/NST-7-50148788/Lower-Cost-Drugs-Predicted-Under-Obama-Administration.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 02 Dec 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50148788/Lower-Cost-Drugs-Predicted-Under-Obama-Administration.aspxPresident George W. Bush blocked, or allowed Republican leaders to stall, several bills that would have resulted in lower drug prices.http://my.packexpo.com/NST-7-50148051/EU-Says-Drugmakers-Blocked-Cheaper-Medicines.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 01 Dec 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50148051/EU-Says-Drugmakers-Blocked-Cheaper-Medicines.aspxEuropean regulators said patients paid some 3 billion euros more than necessary this decade because companies stalled the sale of cheaper generics.http://my.packexpo.com/NST-7-50148056/AstraZeneca-s-New-Lung-Drug-May-Face-U-S-Delay.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 01 Dec 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50148056/AstraZeneca-s-New-Lung-Drug-May-Face-U-S-Delay.aspxThe FDA has requested additional information about motavizumab, which is being proposed for the prevention of respiratory syncytial virus infection.http://my.packexpo.com/NST-7-50146223/Abraxis-Marketing-Deal-With-AstraZeneca-Dissolved.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 26 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50146223/Abraxis-Marketing-Deal-With-AstraZeneca-Dissolved.aspxThe two pharmaceutical companies had been cooperating on introducing the cancer drug Abraxane in the United States.http://my.packexpo.com/NST-7-50146288/Teva-AstraZeneca-Reach-Agreement-on-Marketing-Asthma-Drug.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 26 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50146288/Teva-AstraZeneca-Reach-Agreement-on-Marketing-Asthma-Drug.aspxThe FDA approved Teva's generic version of Pulmicort Respules last week, but AstraZeneca had continued to claim the product infringed on its patents.http://my.packexpo.com/NST-7-50146289/More-Studies-Urged-for-Drugs-Used-Off-Label.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 26 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50146289/More-Studies-Urged-for-Drugs-Used-Off-Label.aspxAuthors of a study reported in the journal Pharmacotherapy identify 14 drugs for which they argue that research into their use for non-FDA-approved indications is most pressing.http://my.packexpo.com/NST-7-50145606/King-Pharma-s-1-6B-Offer-Wins-Over-Alpharma.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 25 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50145606/King-Pharma-s-1-6B-Offer-Wins-Over-Alpharma.aspxAfter Alpharma rejected an initial $1.4 billion offer, King raised its bid and said it would take the offer directly to shareholders.http://my.packexpo.com/NST-7-50145618/J-J-Acquires-Omrix-Biopharmaceutical.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 25 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50145618/J-J-Acquires-Omrix-Biopharmaceutical.aspxThe $438 million deal will enhance Johnson & Johnson's position in the market for suture, mesh, hemostat and other products used during surgery.http://my.packexpo.com/NST-7-50145619/Henry-Schein-to-Exit-Wholesale-Ultrasound-Business.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 25 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50145619/Henry-Schein-to-Exit-Wholesale-Ultrasound-Business.aspxThis business represented sales for the company's Medical Group of approximately $13 million during 2008, and Henry Schein will record a loss from discontinued operations of approximately $6.5 million.http://my.packexpo.com/NST-7-50144847/McKesson-to-Settle-Private-Party-Claims-in-Pricing-Litigation.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 24 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50144847/McKesson-to-Settle-Private-Party-Claims-in-Pricing-Litigation.aspxThe settlement terms, which are subject to final court approval, include an express denial of liability of any kind.http://my.packexpo.com/NST-7-50144872/Johnson-Johnson-Receives-FDA-Approval-for-New-Pain-Med.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 24 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50144872/Johnson-Johnson-Receives-FDA-Approval-for-New-Pain-Med.aspxTapentadol immediate-release tablets are indicated for the relief of moderate to severe acute pain.http://my.packexpo.com/NST-7-50144873/Solvay-Partners-With-Depomed-to-Develop-Gabapentin-GR.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 24 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50144873/Solvay-Partners-With-Depomed-to-Develop-Gabapentin-GR.aspxThe investigational drug is being tested for the treatment of neuropathic pain.http://my.packexpo.com/NST-7-50143857/Roche-Ordered-to-Pay-13M-to-Users-of-Acne-Drug.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 21 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143857/Roche-Ordered-to-Pay-13M-to-Users-of-Acne-Drug.aspxThe money, handed down in New Jersey State Superior Court, will be split among three Floridians who claimed they developed a chronic bowel disorder after using Accutane.http://my.packexpo.com/NST-7-50143864/AstraZeneca-to-Close-European-Plants-Cut-Jobs.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 21 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143864/AstraZeneca-to-Close-European-Plants-Cut-Jobs.aspxThe drug maker also announced plans to expand a packaging and formulation plant in China.http://my.packexpo.com/NST-7-50143865/Pfizer-Ends-Bid-for-OTC-Viagra-in-Europe.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 21 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143865/Pfizer-Ends-Bid-for-OTC-Viagra-in-Europe.aspxThe company has formally withdrawn its European Medicines Agency application for nonprescription status for its ED drug.http://my.packexpo.com/NST-7-50143041/Sanofi-Aventis-Settles-Allergy-Meds-Patent-Cases.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 20 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143041/Sanofi-Aventis-Settles-Allergy-Meds-Patent-Cases.aspxThe French drug maker had sued Barr and Teva over the marketing of generic versions of Allegra and Nasacort.http://my.packexpo.com/NST-7-50143050/FDA-Looks-at-Risks-of-Cosmetic-Face-Fillers.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 20 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143050/FDA-Looks-at-Risks-of-Cosmetic-Face-Fillers.aspxA panel of independent advisers urged the agency to revise the labeling of wrinkle-eliminating injections to include the possibility of long-lasting reactions.http://my.packexpo.com/NST-7-50143136/Teva-Receives-First-U-S-Approval-for-Generic-Pulmicort-Respules.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedThu, 20 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50143136/Teva-Receives-First-U-S-Approval-for-Generic-Pulmicort-Respules.aspxShipment of the low-cost version of the asthma medication has already commenced.http://my.packexpo.com/NST-7-50142276/Medtronic-s-2Q-Profit-Sinks-on-Hefty-Legal-Charge.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 19 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50142276/Medtronic-s-2Q-Profit-Sinks-on-Hefty-Legal-Charge.aspxThe world's largest medical device maker took a hit to its bottom line from a patent settlement with Johnson & Johnson.http://my.packexpo.com/NST-7-50142295/Merck-Voluntarily-Delists-From-Philadelphia-Stock-Exchange.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 19 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50142295/Merck-Voluntarily-Delists-From-Philadelphia-Stock-Exchange.aspxThe company's stock will continue to trade on the New York Stock Exchange.http://my.packexpo.com/NST-7-50142296/Catalent-Introduces-Redesigned-Injectable-Vial.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 19 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50142296/Catalent-Introduces-Redesigned-Injectable-Vial.aspxThe company's Secure-Vial technology was unveiled this week at the annual meeting of the American Association of Pharmaceutical Scientists.http://my.packexpo.com/NST-7-50142392/Salix-Announces-Issuance-of-U-S-Patent-for-Rifaximin.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedWed, 19 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50142392/Salix-Announces-Issuance-of-U-S-Patent-for-Rifaximin.aspxThe patent, valid until August 2019, provides protection relating to using the drug to treat irritable bowel syndrome caused by small intestinal bacterial overgrowth.http://my.packexpo.com/NST-7-50141392/Fake-Pharmaceuticals-The-Wrong-Message-in-a-Bottle.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 18 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50141392/Fake-Pharmaceuticals-The-Wrong-Message-in-a-Bottle.aspxIn Senegal, a 2002 study found that 21 out of 22 samples of the antibiotic ampicillin (of unknown origin) lacked the active ingredient and appeared to contain only flour.http://my.packexpo.com/NST-7-50141439/Life-Science-Abbott-to-Develop-New-Antibody.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 18 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50141439/Life-Science-Abbott-to-Develop-New-Antibody.aspxThe experimental Antibody 806 may prove to be an important tool in the fight against cancer.http://my.packexpo.com/NST-7-50141440/Leading-Pharma-Companies-to-Support-Biotech-Research-Group.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedTue, 18 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50141440/Leading-Pharma-Companies-to-Support-Biotech-Research-Group.aspxRoche, Merck Serono and Abbott yesterday announced their cooperation in developing the Biotechnology Cluster Rhine-Neckar.http://my.packexpo.com/NST-7-50140500/Boehringer-Looking-to-Expand-Mo-Animal-Health-Facility.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 17 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50140500/Boehringer-Looking-to-Expand-Mo-Animal-Health-Facility.aspxThe St. Joseph City Council will vote on a resolution Monday to voice its support and approve an agreement to issue $160 million in industrial revenue bonds for an expansion at Boehringer Ingelheim Vetmedica Inc.http://my.packexpo.com/NST-7-50140501/Javelin-Pharma-to-Reduce-Workforce-by-15-Percent.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedMon, 17 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50140501/Javelin-Pharma-to-Reduce-Workforce-by-15-Percent.aspxThe changes are expected to result in significant cost savings during the company's 2009 fiscal year.http://my.packexpo.com/NST-7-50139353/HPV-Vaccine-for-Women-Also-Prevents-Disease-in-Men.aspx?utm_source=rssfeed&utm_medium=rssfeed&utm_campaign=rssfeedFri, 14 Nov 2008 00:00:00 GMThttp://my.packexpo.com/NST-7-50139353/HPV-Vaccine-for-Women-Also-Prevents-Disease-in-Men.aspxRecently released study results are expected to bolster a likely bid by Gardasil's manufacturer--Merck & Co. Inc.--to begin marketing the vaccine to boys.